Stock exchanges & markets

Overview Watchlists

FDA Approves Alcon's BRYTLY Redness Relief Eye Drops

(AWP Alliance News) - The U.S. FDA approved Alcon's BRYTLY over-the-counter eye drops for redness relief lasting up to 12 hours. The product is expected to reach major retailers nationwide and online in the coming months.

https://www.businesswire.com/news/home/20261016454136/en/

Disclaimer: This news brief was created using generative artificial intelligence. Alcon AG published the original content used to generate this news brief via Business Wire on October 16, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now